International Society of Extracellular Matrix Pharmacology
WELCOME TO ISECMP
A global hub that brings together researchers, healthcare professionals, and industry leaders to shape the future of matrix biology and pharmacology. Founded in 2023 as a non-profit society, ISECMP is dedicated to advancing basic, translational, clinical, and pharmacological research on the extracellular matrix.
Mission Statement
We advance matrix biology and pharmacology by fostering international collaboration, promoting scientific exchange between academia and industry, and supporting research and events that drive innovation in matrix biology to improve human health.
JOIN US!
Membership Benefits
Become a member of ISECMP and enjoy exclusive benefits, including reduced registration fees for the ECM Congress, access to the latest publications, reviews, and industry news in ECM research, as well as opportunities for awards and mentoring that support your research and professional growth.
Reduced Congress Registration Fees
Access to News in ECM Research
Scientific Community
Online membership sign-up coming soon!
Upcoming Events
CONGRESS
We are hosting the 3rd Extracellular Matrix Pharmacology Congress,
and you are invited to join us for some insightful days!
ECM2026 will highlight the role of the ECM in driving therapeutic innovation.
As the first anti-fibrotic therapies reach patients, we have a reason to celebrate — and a responsibility to aim even higher.
Early bird registration is now open! Register for ECM2026 and become a member of ISECMP in one click.
COPENHAGEN, JUNE 14-17, 2026
WEBINAR
Our ECM Pharmacology Symposium Series is held in close collaboration with Nordic Bioscience.
Next webinar:
Fibroblast Activity and ECM Turnover: Biomarkers for Outcomes in Fibrosis and Cancer
Explore why the extracellular matrix (ECM) sits at the center of chronic disease and why fibroblast activity is emerging as a practical, quantifiable lever for prognosis and drug development across fibrosis and oncology.
We will highlight key takeaways from over 700 publications, with a focus on the most decision-relevant insights.
Speakers: Prof., Dr. Morten Karsdal, Dr. Diana Leeming, and Dr. Nicholas Willumsen.
ONLINE, MARCH 10, 2026, 16:00 CET
In the meantime, feel free to watch our previous webinars here.
WE WORK WITH
Media Partners
We acknowledge the collaboration of our media partners, who play an important role in raising awareness of advances in ECM research and related scientific events. In turn, we are committed to supporting our partners, ensuring that together we promote and advance ECM science.
MEET US
Current Board
Morten Karsdal
Chair
CEO, Nordic Bioscience and Adjunct Professor, Southern University of Denmark.
Detlef Schuppan
Board Member
Professor and Director of Molecular and Translational Medicine, University of Mainz.
Andrea Heinz
Board Member
Associate Professor, Department of Pharmacy, University of Copenhagen.
DONATE TO ISECMP
We invite you to support ISECMP in advancing scientific discovery. Your donation will help empower young scientists, promote diversity, enhance ECM biology education, and sustain high-quality scientific events. Contributions also fund travel grants, mentoring programs, and global collaborations — fostering a vibrant and connected research community. Together, we can strengthen the scientific field we all care about.
NEWS AND MEDIA
Latest News
March 10, 2025
Proceedings: ECM Congress 2024
The 2nd ECM Pharmacology Congress (Copenhagen, June 17-19, 2024) brought together 450 experts from 35 countries to share research, explore organ-specific and common disease mechanisms, and showcase technological advances in ECM-targeted drug development.
January 05, 2026
ISECMP Newsletter: 2026 Part I
The ISECMP biannual newsletter is out! The second half of 2025 brought major advances in ECM biology, imaging, fibrosis, and fibro-inflammatory diseases.
February 09, 2026
“Tissue Fibrosis Through the Life Course and in Transplanted Organs”
Fibrosis is a major cause of global morbidity and mortality. Effective therapies to prevent or even reverse existing fibrotic lesions are not yet available. Submit your original research or review on novel signaling pathways and pro-fibrotic mechanisms at all biological levels, as well as pre-clinical studies on therapies for tissue fibrosis, tumor microenvironment biology, and transplanted organ dysfunction.
Submission deadline: April 30, 2026
Editors: Prof. Natasha Rogers and Prof. Yunchao Su
Journal: Physiological Reports